Insights

Niche Market Focus BC3 Technologies specializes in developing antihemorrhagic products for medical, military, and consumer sectors, indicating opportunities to tailor solutions for emergency response teams, defense agencies, and first aid providers expanding their product lines.

Recent Product Launch The recent launch of the professional version of SEAL, adopted by police and EMS organizations nationwide, suggests strong potential for further collaboration with emergency services and public safety institutions seeking advanced hemostatic solutions.

Strategic Partnerships Partnerships with First Aid Only and distribution of SEAL indicate opportunities to expand distribution channels within first aid and safety product markets through channel partners and institutional sales.

Growth Potential Although current revenue is modest, the company's innovative technology and recent product adoption position it well to scale with targeted outreach to governmental, military, and healthcare sectors seeking effective wound management tools.

Technology Differentiator BC3T’s proprietary chitosan-based aerosol product offers high-performance clotting and stability, providing a competitive edge that can be leveraged in marketing efforts to distinguish and expand their product offerings in the hemorrhage control market.

BC3 Technologies Tech Stack

BC3 Technologies uses 8 technology products and services including Concrete CMS, Squarespace, Apple iCloud Mail, and more. Explore BC3 Technologies's tech stack below.

  • Concrete CMS
    Content Management System
  • Squarespace
    Content Management System
  • Apple iCloud Mail
    Email
  • Font Awesome
    Font Scripts
  • Cloudflare Bot Management
    Security
  • Google Tag Manager
    Tag Management
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers

BC3 Technologies's Email Address Formats

BC3 Technologies uses at least 1 format(s):
BC3 Technologies Email FormatsExamplePercentage
First@bc3tech.comJohn@bc3tech.com
50%
First@bc3tech.comJohn@bc3tech.com
50%

Frequently Asked Questions

Where is BC3 Technologies's headquarters located?

Minus sign iconPlus sign icon
BC3 Technologies's main headquarters is located at 715 S Haven St, Baltimore, Maryland 21224, US. The company has employees across 1 continents, including North America.

What is BC3 Technologies's official website and social media links?

Minus sign iconPlus sign icon
BC3 Technologies's official website is bc3tech.com and has social profiles on LinkedInCrunchbase.

What is BC3 Technologies's SIC code NAICS code?

Minus sign iconPlus sign icon
BC3 Technologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BC3 Technologies have currently?

Minus sign iconPlus sign icon
As of October 2025, BC3 Technologies has approximately 4 employees across 1 continents, including North America. Key team members include Chief Executive Officer And President: A. B.Cfo Of Bc3 Technologies: K. S.Coo: L. J.. Explore BC3 Technologies's employee directory with LeadIQ.

What industry does BC3 Technologies belong to?

Minus sign iconPlus sign icon
BC3 Technologies operates in the Biotechnology Research industry.

What technology does BC3 Technologies use?

Minus sign iconPlus sign icon
BC3 Technologies's tech stack includes Concrete CMSSquarespaceApple iCloud MailFont AwesomeCloudflare Bot ManagementGoogle Tag ManagerGoogle AnalyticsApache.

What is BC3 Technologies's email format?

Minus sign iconPlus sign icon
BC3 Technologies's email format typically follows the pattern of First@bc3tech.com. Find more BC3 Technologies email formats with LeadIQ.

How much funding has BC3 Technologies raised to date?

Minus sign iconPlus sign icon
As of October 2025, BC3 Technologies has raised $150K in funding. The last funding round occurred on Feb 01, 2018 for $150K.

When was BC3 Technologies founded?

Minus sign iconPlus sign icon
BC3 Technologies was founded in 2018.

BC3 Technologies

Biotechnology ResearchUnited States2-10 Employees

BC3 Technologies (BC3T, focus is on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors. BC3T’s proprietary chitosan-based aerosol product allows ease of application on wounds as well high-clotting ability which rivals against competitors’ products in both performance and cost. The biggest differentiator for BC3T’s technology compared to others is that the chitosan-based product has maximized hemostatic activity, great stability, and wide-range of applications.

Section iconCompany Overview

Headquarters
715 S Haven St, Baltimore, Maryland 21224, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $150K

    BC3 Technologies has raised a total of $150K of funding over 1 rounds. Their latest funding round was raised on Feb 01, 2018 in the amount of $150K.

  • $1M$10M

    BC3 Technologies's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $150K

    BC3 Technologies has raised a total of $150K of funding over 1 rounds. Their latest funding round was raised on Feb 01, 2018 in the amount of $150K.

  • $1M$10M

    BC3 Technologies's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.